NLP In Healthcare And Life Sciences Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$4,000$10,000

Market for NLP in healthcare and life sciences is projected to exceed USD 5,614 million by 2030 from 1,442 million in 2019, at a CAGR of 20.81% throughout the forecast period i.e. 2020-2030

Clear
SKU: FPG0020 Category: Tags: ,

Description

Market Overview
The market for NLP in healthcare and life sciences is projected to exceed USD 5,614 million by 2030 from 1,442 million in 2019, at a CAGR of 20.81% throughout the forecast period i.e. 2020-2030. The market is anticipated to grow on the back of growing adoption of EHR.
The proliferation of data amounting in healthcare companies has forced vendors to adopt NLP solutions and help clinicians, researchers, and physicians to simplify and manage their decision-making process.
Global NLP in Healthcare and Life Sciences Market: Segments
Services segment to surge at a highest CAGR of xx% during 2020-2030
The global market for NLP in healthcare and life sciences is segmented by component into Standalone Solutions and Services (Support & Maintenance, Professional Services). Among these, services segment is estimated to hold the largest market share of xx% in the year 2019.
Global NLP in Healthcare and Life Sciences Market: Drivers and Restraints
Growing Adoption of EHR
The NLP in healthcare and life sciences market across the globe is mainly driven by the considerable rise in terms of volume of the unorganized clinical information. Growing adoption of the Electronic Health Records (EHR) systems in the healthcare industry is leading to creation of vast amounts of clinical data that comprises of patient details and their diagnosis procedures along with other relevant information such as the details of their medication.
Hampering of Market Growth in the Coming Years
NLP implementation is a major challenge in the healthcare and life sciences sector, which is expected to hamper the market growth over the forecast period. There are many regions in the world where healthcare facilities have a very little access for the general population along with lack of healthcare expenditure expected to hamper the NLP in healthcare and life sciences market.
Global NLP in Healthcare and Life Sciences Market: Regions
North America to grow with the highest CAGR of xx% during 2020-2030
Region-wise, the market for NLP in healthcare and life sciences market is segmented into North America, Latin America, Europe, Middle East & Africa and Asia Pacific. Among these, North America is witnessed to hold the largest market share of xx% in the year 2019 owing to the significant developments in NLP in healthcare and life sciences market.
Global NLP in Healthcare and Life Sciences Market: Key Players
• IBM Corporation
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Health Fidelity
• Wave Health Technologies
• Lexalytics
• Microsoft
• Inovalon
• AWS
• Google
• Dolbey
• Cerner

The global NLP in healthcare and life sciences market report also contains analysis on:
• NLP in Healthcare and Life Sciences Market Segments
o By Component
 Standalone Solutions
 Services
 Support & Maintenance
 Professional Services
o By Application
 Interactive Voice Response
 Pattern & Image Recognition
 Auto Coding
 Classification & Categorization
 Text & Speech Analytics
 Others
 Information Extraction
 Report Generation
o By Deployment Mode
 On-premises
 Cloud
o By End-users
 NLP for Physicians
 NLP for Researchers
 NLP for Patients
 NLP for Clinical Operators
o By Region
 North America
 Latin America
 Europe
 Middle East & Africa
 Asia Pacific
• Optical Coatings Market Dynamics
• Optical Coatings Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Influenza Diagnostics
2.1. Influenza DiagnosticsProduct Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Market Dynamics
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. Recent Development, Policies& Regulatory Landscape
7. Risk Analysis
7.1. Demand Risk Analysis
7.2. Supply Risk Analysis
8. Influenza DiagnosticsIndustry Analysis
8.1. Porters Five Forces
8.1.1. Threat of New Entrants
8.1.2. Bargaining Power of Suppliers
8.1.3. Threat of Substitutes
8.1.4. Rivalry
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. Global Influenza Diagnostics Market
9.1. Market Size & forecast, 2019A-2030F
9.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
9.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10. Global Influenza Diagnostics Market: Market Segmentation
10.1. By Regions
10.1.1. North America: (U.S. and Canada)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2. By Test Type: Market Share (2020-2030F)
10.2.1. Traditional Diagnostics Tests, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.2.2. Molecular Diagnostic Tests, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3. By Type of Flu:Market Share (2020-2030F)
10.3.1. Type A, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.2. Type B, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.3.3. Type C, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.By End User: Market Share (2020-2030F)
10.4.1. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.2. Clinical Laboratories, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.3. Research Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.3. Point of Care Testing Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.4 Other End User, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. Company Profile
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Company Total Revenue (Financials)
11.1.3. Market Potential
11.1.4. Global Presence
11.1.5. Key Performance Indicators
11.1.6. SWOT Analysis
11.1.7. Product Launch
11.2. Siemens Healthineers
11.3. Analytik Jena
11.4. Quidel Corporation
11.5. Genome Diagnostics
11.6. Meridian Bioscience
11.7. BioMerieux SA
11.8. Sekisui Diagnostics
11.9. Response Biomedical
11.10. SA Scientific
11.11. Enigma Diagnostics
11.12. Focus Diagnostics
12. Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

RSS
Follow by Email